Oxford Immunotec Enters into Definitive Agreement to Acquire Imugen
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/25/2026
- S&P 500, Nasdaq end down on tech stocks, investors weigh Iran moves
- Oil drops more than $2 despite new US sanctions on Iran
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- Wattmore and Eos Energy strike non-exclusive storage software deal
- Grand Canyon Education places CFO on leave amid stock trade probe
- S&P 500, Nasdaq end down on tech stocks, investors weigh Iran moves
- Funds sell $44bn in semiconductors on AI concerns
- RUM Group signs $13.7 billion GPU services deal, issues warrants
BTIG Keeps Oxford Immunotec (OXFD) at 'Buy' Amid Imugen Deal; Sees Few Negatives
June 27, 2016 6:40 AM EDTBTIG affirms Oxford Immunotec Global PLC (Nasdaq: OXFD) at Buy with a price target of $17 after the company announced that it entered an agreement to... More
